Search Within

Yingbei Chen

  1. "Computational Oncology Service"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (15)
Groups
  1. Computational Oncology Service (32)
  2. Department of Pathology and Laboratory Medicine (32)
  3. Epidemiology and Biostatistics (32)
  4. GSK Faculty (32)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (29)
  6. Department of Medicine (29)

More Groups

People
  1. Abraham Hakimi (23)
  2. Eduard Reznik (22)
  3. Robert Motzer (21)
  4. Paul Russo (20)
  5. Martin Voss (19)
  6. Victor Reuter (19)

More People

Years
  1. 2024 (3)
  2. 2023 (4)
  3. 2022 (5)
  4. 2021 (4)
  5. 2019 (3)
  6. 2017 (2)

More Years

Publications
  1. European Urology Focus (4)
  2. Journal of Clinical Oncology (4)
  3. Laboratory Investigation (4)
  4. Clinical Cancer Research (3)
  5. Modern Pathology (3)
  6. European Urology (2)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. American Society of Clinical Oncology (5)
  3. Nature Publishing Group (5)
  4. Elsevier B.V. (4)
  5. Nature Research (3)
  6. Elsevier Inc. (2)

More Publishers

Results (32)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of cabozantinib plus nivolumab in patients with non-clear-cell renal cell carcinoma and genomic correlates
    Journal Article

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Zucker, M.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Dadoun, C.; Reznik, E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Molecular characterization of the tumor microenvironment in renal medullary carcinoma
    Journal Article

    Tourigny, D. S.; Zucker, M.; Kim, M.; Russo, P.; Coleman, J.; Lee, C. H.; Carlo, M. I.; Chen, Y. B.; Hakimi, A. A.; Kotecha, R. R.; more...
    Frontiers in Oncology (2022)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Results of a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Reznik, E.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Tassone, D.; Dadoun, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Neutrophil-to-lymphocyte ratio in unclassified renal cell carcinoma is associated with clinical outcome and varies between genomic subgroups
    Meeting Abstract

    Marcon, J.; Di Natale, R. G.; Weng, S.; Ghanaat, M.; Silagy, A. W.; Mano, R.; Blum, K. A.; Attalla, K.; Reznik, E.; Carlo, M. I.; more...
    European Urology (2021)

    Fulltext@MSK | Save
  • Comprehensive molecular characterization and response to therapy in fumarate hydratase-deficient renal cell carcinoma
    Journal Article

    Gleeson, J. P.; Nikolovski, I.; Dinatale, R.; Zucker, M.; Knezevic, A.; Patil, S.; Ged, Y.; Kotecha, R. R.; Shapnik, N.; Murray, S.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Putative drivers of aggressiveness in TCEB1-mutant renal cell carcinoma: An emerging entity with variable clinical course
    Journal Article

    DiNatale, R. G.; Gorelick, A. N.; Makarov, V.; Blum, K. A.; Silagy, A. W.; Freeman, B.; Chowell, D.; Marcon, J.; Mano, R.; Sanchez, A.; more...
    European Urology Focus (2021)

    Fulltext@MSK | Save
  • Comprehensive genomic analysis of metastatic non–clear-cell renal cell carcinoma to identify therapeutic targets
    Journal Article

    Carlo, M. I.; Khan, N.; Zehir, A.; Patil, S.; Ged, Y.; Redzematovic, A.; Coskey, D. T.; Hyman, D. M.; Ladanyi, M.; Chen, Y. B.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Characterization and impact of TERT promoter region mutations on clinical outcome in renal cell carcinoma
    Journal Article

    Casuscelli, J.; Becerra, M. F.; Manley, B. J.; Zabor, E. C.; Reznik, E.; Redzematovic, A.; Arcila, M. E.; Tennenbaum, D. M.; Ghanaat, M.; Kashan, M.; more...
    European Urology Focus (2019)

    Fulltext@MSK | Save
  • Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma
    Journal Article

    Xu, J.; Reznik, E.; Lee, H. J.; Gundem, G.; Jonsson, P.; Sarungbam, J.; Bialik, A.; Sanchez-Vega, F.; Creighton, C. J.; Hoekstra, J.; more...
    eLife (2019)

    Fulltext@MSK | Save
  • Tumor xenografts of human clear cell renal cell carcinoma but not corresponding cell lines recapitulate clinical response to sunitinib: Feasibility of using biopsy samples
    Journal Article

    Dong, Y.; Manley, B. J.; Becerra, M. F.; Redzematovic, A.; Casuscelli, J.; Tennenbaum, D. M.; Reznik, E.; Han, S.; Benfante, N.; Chen, Y. B.; more...
    European Urology Focus (2017)

    Fulltext@MSK | Save